2024 annual financial data
Edesa Biotech 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -7,014,744 USD and net income was -6,170,045 USD.
Operating cash flow was -4,890,205 USD.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,014,744 USD
- Net income
- -6,170,045 USD
- Operating cash flow
- -4,890,205 USD